Genetic testing to detect germline RET mutation should also be offered to patients with apparent sporadic MTC, as hereditary disease may be seen in 1–7% of presumed sporadic MTC [19,43,44,45]. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.